Literature DB >> 7485580

Effects of indomethacin on brain blood flow, cerebral metabolism, and sagittal sinus prostanoids after hypoxia.

M G Coyle1, W Oh, K H Petersson, B S Stonestreet.   

Abstract

We tested the hypotheses that during recovery from hypoxia, newborn piglets exhibit a posthypoxic cerebral hyperemia, indomethacin-pretreated piglets exhibit a posthypoxic cerebral hypoperfusion, and that the changes caused by indomethacin are dose dependent and related to the loss of prostanoids. We studied piglets exposed to 40 min of hypoxia after pretreatment with high (5 mg/kg, n = 9) or low (0.3 mg/kg, n = 8) doses of indomethacin or placebo (n = 9) and allowed to recover for 120 min. In the placebo and low-dose pretreatment groups, total and regional brain blood flow increased during hypoxia but returned to baseline 10 min after hypoxia. High-dose indomethacin pretreatment was associated with a posthypoxic hypoperfusion to certain brain regions at 10 min of recovery to values similar to those after indomethacin treatment before the onset of hypoxia. During and after hypoxia, the cerebral metabolic rate of oxygen was preserved in both the placebo and low-dose groups and decreased significantly during hypoxia in the high-dose group. Sagittal sinus prostacyclin was reduced significantly in both indomethacin-treated groups throughout the study. We conclude that a posthypoxic hyperemia is not observed in newborn piglets. This finding was not altered by pretreatment with a therapeutic dose of indomethacin, whereas a pharmacological dose was associated with selective hypoperfusion to certain brain regions both before hypoxia and during recovery from hypoxia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485580     DOI: 10.1152/ajpheart.1995.269.4.H1450

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Influence of indomethacin on the ventilatory and cerebrovascular responsiveness to hypoxia.

Authors:  Jui-Lin Fan; Keith R Burgess; Kate N Thomas; Karen C Peebles; Samuel J E Lucas; Rebekah A I Lucas; James D Cotter; Philip N Ainslie
Journal:  Eur J Appl Physiol       Date:  2010-10-12       Impact factor: 3.078

Review 2.  Pathogenesis and prevention of intraventricular hemorrhage.

Authors:  Praveen Ballabh
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

3.  Cyclooxygenase-derived vasoconstriction restrains hypoxia-mediated cerebral vasodilation in young adults with metabolic syndrome.

Authors:  John W Harrell; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

4.  Indomethacin prophylaxis to prevent intraventricular hemorrhage: association between incidence and timing of drug administration.

Authors:  Hussnain Mirza; William Oh; Abbot Laptook; Betty Vohr; Richard Tucker; Barbara S Stonestreet
Journal:  J Pediatr       Date:  2013-03-22       Impact factor: 4.406

5.  Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants.

Authors:  Hussnain Mirza; Abbot R Laptook; William Oh; Betty R Vohr; Barbara J Stoll; Sarah Kandefer; Barbara S Stonestreet
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-01-05       Impact factor: 5.747

6.  Influence of cerebral blood flow on breathing stability.

Authors:  Ailiang Xie; James B Skatrud; Steven R Barczi; Kevin Reichmuth; Barbara J Morgan; Sara Mont; Jerome A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2008-12-31

7.  Regional Differences in the Neuronal Expression of Cyclooxygenase-2 (COX-2) in the Newborn Pig Brain.

Authors:  Orsolya Oláh; István Németh; Valéria Tóth-Szűki; Ferenc Bari; Ferenc Domoki
Journal:  Acta Histochem Cytochem       Date:  2012-05-15       Impact factor: 1.938

8.  Use of Prophylactic Indomethacin in Preterm Infants: A Systematic Review and Meta-Analysis.

Authors:  Abdulrahman Al-Matary; Amani Abu Shaheen; Sameh Abozaid
Journal:  Front Pediatr       Date:  2022-04-07       Impact factor: 3.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.